semaglutide vs tirzepatide clinical comparison 𧬠vs RETATRUTIDE 𧬠Understanding the difference could help you make more informed decisions about weight management and metabolic health. π πΉ Semaglutide Targets GLP-1 receptors to help reduce Tirzepatide vs Semaglutide: 2026 Clinical
Description
If a patient eats too little, loses too much lean muscle, becomes dehydrated, or avoids protein because of nausea, the scale may move while metabolic health suffers

Some individuals respond extremely well to semaglutide, while others may benefit more from tirzepatides dual-action approach
The trial data supports this

In the SURMOUNT-5 trial, mean weight change at 72 weeks was greater with tirzepatide

A provider may discuss switching from semaglutide to tirzepatide if progress has slowed, appetite control is not adequate, side effects are manageable and the patients health history supports the change
